Results 51 to 60 of about 350,979 (277)

Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors [PDF]

open access: yes, 2017
Objectives To characterize the prevalence of transmitted drug resistance mutations (TDRMs) by plasma analysis of 750 patients at the time of HIV diagnosis from January 1, 2013 to November 16, 2016 in the Veneto region (Italy), where all drugs included in
Alvarez, M   +18 more
core   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity

open access: yesHuman Genomics, 2023
Background The use of molecular biomarkers for COVID-19 remains unconclusive. The application of a molecular biomarker in combination with clinical ones that could help classifying aggressive patients in first steps of the disease could help clinician ...
Silvia Martinez-Diz   +10 more
doaj   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

open access: yesFrontiers in Immunology, 2022
Autologous T cells expressing the Chimeric Antigen Receptor (CAR) have been approved as advanced therapy medicinal products (ATMPs) against several hematological malignancies.
Noelia Maldonado-Pérez   +22 more
doaj   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Representation of "Disease" by mothers of adolescent childhood cancer survivors

open access: yesПсихология и Психотерапия Семьи, 2018
To describe representations of "disease" in families with adolescent childhood cancer survivors. Method: Participants were 8 mothers with experience of encounter of childhood cancer and 7 mothers without it. They chose one picture from TAT as association
Julia Bykhovets, Phd, Lina Kogan-Lerner
doaj  

Mitigating gas migration with eutectic bismuth alloy plugs

open access: yesPetroleum Research
Gas migration is an important concern to address in oil wells, especially in those that are to be abandoned. Stopping a gas leakage is not a simple task, and this can be particularly detrimental when setting a cement plug, as the migrated gas can ...
Lewaa Hmadeh   +4 more
doaj   +1 more source

Potential of the Other Genetic Information Coded by the Viral RNA Genomes as Antiviral Target

open access: yesPharmaceuticals, 2019
In addition to the protein coding information, viral RNA genomes code functional information in structurally conserved units termed functional RNA domains.
Alfredo Berzal-Herranz   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy